Bone Turnover Markers and Adipocytokinesresponse to Weight Reduction among Obese Patients with Type 2 Diabetes Mellitus| Stephy Publishers
SOJ Diabetes and Endocrinology
Care - (SOJDEC)| Stephy Publishers
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a highly prevalent
disease associated with increased the risk of fracture due to altered bone
micro architecture and/or poor quality as key factors. Bone remodeling appears
to be impaired among patients with T2DM as both markers of bone formation and
markers of bone resorption are decreased when compared to healthy subjects.
Objective: This study aimed to detect if weight reduction
modulates adipokines and markers of bone turnover among T2DM patients.
Material and Methods: Eighty obese patients with T2DM (46 men and
34 women), their age ranged from 40-53 years and their body mass index ranged
from 30-36 kg/m2 were equally assigned into 2 groups: the weight reduction
group received aerobic exercises, diet regimen, where the control group
received medical treatment only for 6 months.
Results: The mean values of body mass index (BMI), leptin,
resistin, visfatin levels significantly decreased, however the mean values of
adiponectin, bone alkaline phosphatase (BAP) and serum cross-linked
N-telopeptides of type I collagen (NTX) levels significantly increased in the
training group. While, the results of the control group were not significant.
In addition, there were significant differences between both groups at the end
of the study.
Conclusion: Weight loss ameliorates adipocytokines and bone
turnover markers among obese patients with type 2 diabetes mellitus.
Keywords
Aerobic exercise, Bone turnover, Type 2 diabetes mellitus,
Adipokines, Diet regimen
Introduction
Globally, Type 2 diabetes mellitus (T2DM) will reach 438 million
by 2030.1 Bone damage is a common complication after diabetes mellitus.2,3
Despite there is an evidence that T2DM is related to poor bone quality and
micro architecture that elevate the risk of bone fragility and fracture.4
Type 2 diabetes mellitus (T2DM) is a main cause for cardiovascular
dysfunctions,5-7 the risk of coronary artery disease is 2-4 times among
diabetics than non-diabetics and peripheral vascular diseases risk is ten times
greater among diabetics than non-diabetics.8,9
Bone turnover biomarkers (BTMs) indicate the bone remodeling
status that includes both bone resorption and formation.9 There an impairment
in bone remodeling among patients with diabetes, where bone formation
biomarkers and bone resorption biomarkers are reduced.10-13 Although T2DM
patients have higher bone marrow density (BMD), the fracture risk is higher
among them.14,15 Therefore, BTMs are more sensitive markers than BMD for bone
fracture risk, due to possible link between blood glucose metabolism and
BTMs.16,17
Bone turnover biomarkers are markers for measure rate of
resorption and formation. Osteoblast is responsible for synthesis of bone
formation biomarkers, so that reflect certain function of osteoblast18,19 that
considered as bone formation markers which are predictors for hip fracture risk
and osteoporosis.20-25
The purpose of
this study was to determine the effects of weight reduction on bone turnover
markers and adipocytokines among obese patients with T2DM.
To read
more #EndocrinologyCare #SOJDEC
https://www.stephypublishers.com/sojdec/fulltext/SOJDEC.MS.ID.000506.php
#Openaccessjournals
https://www.stephypublishers.com/
Comments
Post a Comment